Pneuma Pharmaceuticals Incorporated   Report issue

For profit Phase 1 Phase 3
Founded: Boone NC United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2015
NCT00682500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Pneuma Respiratory, Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

calfactant (infasurf) (1 trial)

Drugs in Phase 1 Trials (2)

albuterol (proventil) (1 trial)

ipratropium (atrovent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3